Alcohol Withdrawal Superimposed on Cirrhosis With Prior Seizures
A 47-year-old man with alcohol use disorder is admitted 36 hours after his last drink with tremor, diaphoresis, and agitation. He has Child-Pugh class B cirrhosis, ascites, and thrombocytopenia (platelets 78,000/µL). Home medications include furosemide and spironolactone; he has had two prior withdrawal seizures, one requiring ICU admission. Vitals: HR 118/min, BP 168/96 mmHg, temp 37.8°C, RR 20/min, SpO2 96% on room air. He is oriented to person and place but not date; he has asterixis. CIWA-Ar score is 18. Labs: INR 1.6, total bilirubin 2.8 mg/dL, albumin 2.9 g/dL, ammonia 78 µmol/L, creatinine 1.1 mg/dL, glucose 92 mg/dL, sodium 132 mmol/L. He is tremulous and reports 'bugs on the wall.' No fever, no hematemesis; abdomen is distended with shifting dullness.
1. How should you distinguish alcohol withdrawal from hepatic encephalopathy in this patient, and why does the distinction matter for treatment?
Read the worked answer
The two conditions overlap, and this patient has features of both. Tremor, diaphoresis, tachycardia, hypertension, and visual hallucinations point toward alcohol withdrawal. Asterixis, disorientation, ascites, and cirrhosis point toward hepatic encephalopathy. Ammonia is neither sensitive nor specific and should not be used alone to rule either diagnosis in or out.
The distinction matters because benzodiazepines treat withdrawal but can worsen encephalopathy, while lactulose treats encephalopathy but does not treat withdrawal. Look for precipitants of encephalopathy such as infection, gastrointestinal bleeding, constipation, or electrolyte disturbance. A CIWA-Ar score may overestimate withdrawal in a patient who is encephalopathic. Treat the withdrawal component while simultaneously evaluating and managing encephalopathy.
2. Select a benzodiazepine strategy and monitoring plan, accounting for cirrhosis and prior seizures.
Read the worked answer
Use lorazepam, which undergoes glucuronidation and is less dependent on hepatic oxidation than diazepam or chlordiazepoxide. A symptom-triggered regimen is reasonable, but because of prior withdrawal seizures, many clinicians would give scheduled lorazepam for the first 24–48 hours and then switch to symptom-triggered dosing. Avoid long-acting benzodiazepines in decompensated cirrhosis because of accumulation and worsening encephalopathy.
Give thiamine before or with glucose, and replace folate and magnesium as needed. Monitor sedation, respiratory rate, blood pressure, and serial neurologic examinations. Do not use phenobarbital as a routine withdrawal treatment in this patient. If a seizure occurs, treat it as a medical emergency and consider a loading dose of lorazepam with airway support. Look for infection and gastrointestinal bleeding, which can precipitate both withdrawal and encephalopathy.
3. What discharge medications and supports reduce relapse and readmission?
Read the worked answer
Acamprosate is a reasonable option because it is not hepatically metabolized, though renal function and adherence matter. Naltrexone requires caution because of hepatotoxicity and is generally avoided in severe liver disease. Disulfiram is contraindicated in cirrhosis. There is no single 'best' medication; the choice depends on liver function, cravings, and patient preference.
Arrange addiction medicine follow-up, thiamine supplementation, and treatment of ascites and other complications. Address housing, transportation, and social triggers. A brief motivational interview plus a concrete follow-up appointment reduces readmission more than a warning alone. Consider gabapentin or topiramate only with specialist input, and document why other agents were rejected.